Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Kaminski

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Obstetrical & Gynecological Survey|March 19, 2016
Contemporary Obstetric TriageEdward Allen Sandy, Robert Kaminski, Hygriv Simhan, et al.
Journal of the American Dental Association (1939)|March 9, 2006
Knowing how to help tobacco users. Dentists' familiarity and compliance with the clinical practice guidelineShaohua Hu, Unto Pallonen, Alfred L McAlister, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Vaccine|July 3, 2023
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistryMeagan Kelly, Anjali Mandlik, Richelle C Charles, et al.
Vaccine|November 30, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshopsShahida Baqar, Aurelio Bonavia, A Louis Bourgeois, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Obstetrical & Gynecological Survey|March 19, 2016
Contemporary Obstetric TriageEdward Allen Sandy, Robert Kaminski, Hygriv Simhan, et al.
Journal of the American Dental Association (1939)|March 9, 2006
Knowing how to help tobacco users. Dentists' familiarity and compliance with the clinical practice guidelineShaohua Hu, Unto Pallonen, Alfred L McAlister, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Vaccine|July 3, 2023
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistryMeagan Kelly, Anjali Mandlik, Richelle C Charles, et al.
Vaccine|November 30, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshopsShahida Baqar, Aurelio Bonavia, A Louis Bourgeois, et al.
Pageof 1